Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

What Analysts Are Saying About Omega Healthcare Invts Stock

Author: Benzinga Insights | September 04, 2024 12:00pm

In the last three months, 4 analysts have published ratings on Omega Healthcare Invts (NYSE:OHI), offering a diverse range of perspectives from bullish to bearish.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 0 4 0 0
Last 30D 0 0 1 0 0
1M Ago 0 0 1 0 0
2M Ago 0 0 1 0 0
3M Ago 0 0 1 0 0

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $36.0, a high estimate of $39.00, and a low estimate of $33.00. This upward trend is apparent, with the current average reflecting a 10.77% increase from the previous average price target of $32.50.

price target chart

Breaking Down Analyst Ratings: A Detailed Examination

A comprehensive examination of how financial experts perceive Omega Healthcare Invts is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Michael Lewis Truist Securities Raises Hold $39.00 $33.00
Nicholas Yulico Scotiabank Raises Sector Perform $39.00 $33.00
Nicholas Yulico Scotiabank Raises Sector Perform $33.00 $32.00
Michael Lewis Truist Securities Raises Hold $33.00 $32.00

Key Insights:

  • Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Omega Healthcare Invts. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Omega Healthcare Invts compared to the broader market.
  • Price Targets: Delving into movements, analysts provide estimates for the future value of Omega Healthcare Invts's stock. This analysis reveals shifts in analysts' expectations over time.

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Omega Healthcare Invts's market standing. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Omega Healthcare Invts analyst ratings.

All You Need to Know About Omega Healthcare Invts

Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).

Financial Insights: Omega Healthcare Invts

Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.

Revenue Growth: Omega Healthcare Invts's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 1.02%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.

Net Margin: Omega Healthcare Invts's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 45.05%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): Omega Healthcare Invts's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.15% ROE, the company effectively utilizes shareholder equity capital.

Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.27%, the company showcases effective utilization of assets.

Debt Management: Omega Healthcare Invts's debt-to-equity ratio is below the industry average at 1.26, reflecting a lower dependency on debt financing and a more conservative financial approach.

Understanding the Relevance of Analyst Ratings

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: OHI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist